- 专利标题: Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
-
申请号: US10550222申请日: 2004-03-19
-
公开(公告)号: US20060276485A1公开(公告)日: 2006-12-07
- 发明人: Michael Soeberdt , Philip Weyermann , Andreas Von Sprecher
- 申请人: Michael Soeberdt , Philip Weyermann , Andreas Von Sprecher
- 优先权: EP03006253.3 20030320
- 国际申请: PCT/EP04/02908 WO 20040319
- 主分类号: A61K31/496
- IPC分类号: A61K31/496 ; A61K31/4709 ; A61K31/454 ; C07D405/14 ; C07D403/14
摘要:
The present invention relates to novel substituted piperidine and piperazine derivatives as melanocortin-4 receptor (MC-4R) modulators. MC-4R agonists of the invention can be used for the treatment of disorders and diseases such as obesity, diabetes, and sexual dysfunction, whereas the MC-4R antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. All diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.